FOXO transcription factors at the interface of metabolism and cancer
Abstract
Diabetes refers to a group of metabolic diseases characterized by impaired insulin signalling and high blood glucose. A growing body of epidemiological evidence links diabetes to several types of cancer but the underlying molecular mechanisms are poorly understood. The signalling cascade connecting insulin and FOXO proteins provides a compelling example for a conserved pathway at the interface between insulin signalling and cancer. FOXOs are transcription factors that orchestrate programs of gene expression known to control a variety of processes in response to cellular stress. Genes regulated by this family of proteins are involved in the regulation of cellular energy production, oxidative stress resistance and cell viability and proliferation. Accordingly, FOXO factors have been shown to play an important role in the suppression of tumour growth and in the regulation of metabolic homeostasis. There is emerging evidence that deregulation of FOXO factors might account for the association between insulin resistance‐related metabolic disorders and cancer.
Number of times cited according to CrossRef: 9
- Susana Machado, Catarina Raposo, Bibiana I. Ferreira and Wolfgang Link, Image-based Identification of Chemical Compounds Capable of Trapping FOXO in the Cell Nucleus, FOXO Transcription Factors, 10.1007/978-1-4939-8900-3_14, (163-170), (2018).
- Marta Barradas, Wolfgang Link, Diego Megias and Pablo J. Fernandez-Marcos, High-Throughput Image-Based Screening to Identify Chemical Compounds Capable of Activating FOXO, FOXO Transcription Factors, 10.1007/978-1-4939-8900-3_13, (151-161), (2018).
- Doug Hanniford and Eva Hernando, Characterization of MicroRNAs Regulating FOXO Expression, FOXO Transcription Factors, 10.1007/978-1-4939-8900-3_2, (13-28), (2018).
- Wolfgang Link, Introduction to FOXO Biology, FOXO Transcription Factors, 10.1007/978-1-4939-8900-3_1, (1-9), (2018).
- Zhenzhen Hu, Feng Wang, Zhen Wu, Hao Gu, Na Dong, Xiuqin Jiang, Jinjin Xu, Zhiwei Wu, Daniel S. Wechsler and Datong Zheng, FOXO3a-dependent up-regulation of Mxi1-0 promotes hypoxia-induced apoptosis in endothelial cells, Cellular Signalling, 10.1016/j.cellsig.2018.08.009, 51, (233-242), (2018).
- Zhiqiang Ma, Zhenlong Xin, Wei Hu, Shuai Jiang, Zhi Yang, Xiaolong Yan, Xiaofei Li, Yang Yang and Fulin Chen, Forkhead box O proteins: Crucial regulators of cancer EMT, Seminars in Cancer Biology, 10.1016/j.semcancer.2018.02.004, (2018).
- Ya-qi Xing, Ang Li, Yang Yang, Xiao-xia Li, Li-nan Zhang and Hui-cai Guo, The regulation of FOXO1 and its role in disease progression, Life Sciences, 10.1016/j.lfs.2017.11.030, 193, (124-131), (2018).
- Renae J. Stefanetti, Sarah Voisin, Aaron Russell and Séverine Lamon, Recent advances in understanding the role of FOXO3, F1000Research, 10.12688/f1000research.15258.1, 7, (1372), (2018).
- Jianan Yang, Bin Wang, Han Chen, Xuhong Chen, Jing Li, Yanfei Chen, Daozhang Yuan and Shunsheng Zheng, Thyrotroph embryonic factor is downregulated in bladder cancer and suppresses proliferation and tumorigenesis via the AKT/FOXOs signalling pathway, Cell Proliferation, e12560, (2018).
